Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 162Carcinoma, Non-Small-Cell Lung 109Lung Neoplasms 54Hodgkin Disease 22Neoplasm Metastasis 16Recurrence 15Lymphoma 15Neoplasms 14Triple Negative Breast Neoplasms 13Prostatic Neoplasms 10Adenocarcinoma of Lung 10Sarcoma 9Rhabdomyosarcoma 9Uterine Cervical Neoplasms 8Lymphoma, Non-Hodgkin 8Lymphoma, Large B-Cell, Diffuse 6Ovarian Neoplasms 5Mesothelioma, Malignant 5Breast Neoplasms, Male 5Small Cell Lung Carcinoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4NSCLC 4Multiple Myeloma 4Brain Neoplasms 4Unspecified Adult Solid Tumor, Protocol Specific 3Mesothelioma 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3

Interventions

Docetaxel 3Carboplatin 3motexafin gadolinium 2figitumumab 2cemiplimab 2alpha-2'-deoxythioguanosine 2Paclitaxel 2vandetanib 1temoporfin 1tanespimycin 1brigatinib 1Vinorelbine 1Temozolomide 1Radiotherapy 1Radiosurgery 1Pemetrexed 1Oxaliplatin 1Gemcitabine 1Everolimus 1Erlotinib Hydrochloride 1Crizotinib 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Large Cell × Vinorelbine × Clear all
NCT06908304 2026-01-12

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC

Maia Biotechnology

Phase 3 Recruiting
300 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡